Early research (Phase 1)Study completedNCT03126591
What this trial is testing
Olaratumab (LY3012207) Plus Pembrolizumab in Participants With Advanced or Metastatic Soft Tissue Sarcoma
Who this might be right for
Soft Tissue Sarcoma
Eli Lilly and Company 41